TrialJournal of global antimicrobial resistance2022

Pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacin.

Susanne Paukner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.